Search

everythinglearnresearchcommunity

for

Search:↓

Personal and environmental factors influence skin diseases.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Premature gray hair may indicate reduced ovarian reserve but doesn't lower pregnancy chances.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Healthy lifestyle changes, especially weight loss, can improve symptoms and overall health in people with Polycystic Ovary Syndrome, especially if they are overweight or obese.

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

A standardized patch test for hair cosmetics is needed in Europe to prevent allergies, especially for hairdressers.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

AI is revolutionizing non-surgical cosmetic procedures by improving personalization, safety, and access.

Higher cannabis exposure may lead to increased hair loss.

Personalized skin rejuvenation using genomics shows promise but needs more research.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

AI and robotics are improving treatment and monitoring of neurodegenerative disorders like Parkinson's.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Monitoring steroid hormones in blood can better detect testosterone doping.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.